We are pleased to inform that the Economic Legislation Review (No. 3) published an article by Marta Łanoch on legal issues of probiotic declarations. We invite those interested to read it!
In the journal “World of the Pharmaceutical Industry” (No. 4/2019) Marta Łanoch discusses products from the borderland. Those interested are invited to read the article!
From 1 April 2020, new requirements for indicating the country of origin or place of provenance of the primary ingredient on the label apply. Doubts and problems of interpretation related to this have been discussed by Marta Łanoch in the quarterly “World of the Pharmaceutical Industry”. Those interested are invited to read the article.
The ban on advertising pharmacies is incompatible with the fundamental freedoms of the European Union’s internal market – this is the European Commission’s opinion addressed to the Polish government. The Lewiatan Confederation filed a complaint with the European Commission claiming that the ban on advertising of pharmacies in Poland may restrict the freedoms of the internal market. If the Polish…
In a recent CND meeting behind closed doors, participants discussed two of the six WHO recommendations on cannabis: – removal of cannabis “extracts and tinctures” from Schedule 1 to the Single Convention on Narcotic Drugs, 1961. – adding a footnote to the entry for cannabis in Schedule 1 of the 1961 Single Convention to clarify that preparations containing mainly CBD…